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Perturbations of cell surface synapse-organizing
proteins, particularly a-neurexins, contribute to neu-
rodevelopmental and psychiatric disorders. From
an unbiased screen, we identify calsyntenin-3
(alcadein-b) as a synapse-organizing protein unique
in binding and recruiting a-neurexins, but not
b-neurexins. Calsyntenin-3 is present in many pyra-
midal neurons throughout cortex and hippocampus
but is most highly expressed in interneurons. The
transmembrane form of calsyntenin-3 can trigger
excitatory and inhibitory presynapse differentiation
in contacting axons. However, calsyntenin-3-shed
ectodomain, which represents about half the calsyn-
tenin-3 pool in brain, suppresses the ability of multi-
ple a-neurexin partners including neuroligin 2 and
LRRTM2 to induce presynapse differentiation.
Clstn3/ mice show reductions in excitatory and
inhibitory synapse density by confocal and electron
microscopy and corresponding deficits in synaptic
transmission. These results identify calsyntenin-3
as an a-neurexin-specific binding partner required
for normal functional GABAergic and glutamatergic
synapse development.
INTRODUCTION
Synapse-organizing complexes mediate local differentiation of
presynaptic and postsynaptic specializations by recruiting mo-
lecular components and organelles involved in neurotransmitter
release and reception. Emerging evidence indicates that multiple
synapse-organizing complexes act in concert to regulate the
density, composition, and function of synapses on each neuron
(Missler et al., 2012; Shen and Scheiffele, 2010; Siddiqui and
Craig, 2011).The presynaptic neurexins constitute one of the best-charac-
terized families of synapse-organizing proteins (Krueger et al.,
2012; Su¨dhof, 2008). Each of the three neurexin genes in
humans and rodents produces long a isoforms from an
upstream promoter and shorter b isoforms from a downstream
promoter. Alternative splicing creates additional diversity
resulting in >3,000 potential neurexin isoforms (Tabuchi and
Su¨dhof, 2002). Importantly, a-neurexins perform essential func-
tions that are not shared with b-neurexins. Mice that lack
a-neurexins but express normal b-neurexin levels die at birth
due to major deficits in synaptic function (Missler et al.,
2003), and synaptic transmission can only be rescued by trans-
genic expression of neurexin-1a, but not of neurexin-1b (Zhang
et al., 2005). Neurexins have acquired particular notoriety
because alterations in NRXN genes were found to contribute
to nonsyndromic autism spectrum disorders and schizophrenia
(Betancur et al., 2009; Su¨dhof, 2008; Autism Genome
Project Consortium et al., 2007). Interestingly, the majority of
disease-associated NRXN variations selectively affect a-neu-
rexins, and not b-neurexins (Ching et al., 2010; Gauthier
et al., 2011; Schaaf et al., 2012; Vaags et al., 2012). Despite
the obvious functional importance of a-neurexins, and the
identification of multiple extracellular partners for neurexin
isoforms, the only identified a-neurexin-specific interacting pro-
teins are the small secreted neuropeptide-like neurexophilins
(Missler and Su¨dhof, 1998).
Neurexins control excitatory and inhibitory synapse develop-
ment through isoform-selective interactions with different sets
of postsynaptic partners. Neuroligins were the first postsyn-
aptic neurexin interactors to be identified. As with neurexins,
mutations in NLGN genes are linked to neurodevelopmental
disorders (Jamain et al., 2003; Krueger et al., 2012; Su¨dhof,
2008), and animal models support a causative role (e.g.,
Jamain et al., 2008). The main neuroligin at glutamatergic syn-
apses, neuroligin 1 (with the B insert), binds only b-neurexins,
whereas the other neuroligins, including neuroligin 2, which is
the main neuroligin of GABAergic synapses, bind all neurexins
(Boucard et al., 2005). Acting cooperatively with neuroligins at
subsets of glutamatergic synapses, postsynaptic LRRTM1Neuron 80, 113–128, October 2, 2013 ª2013 Elsevier Inc. 113
Figure 1. Calsyntenin-3 Induces Excitatory and Inhibitory Presynapse Differentiation
(A) COS cells expressing Myc-calsyntenin-3-CFP (Myc-C3-CFP) induce the formation of presynaptic specializations in contacting axons of cocultured hippo-
campal neurons. Induced presynaptic sites show synapsin clustering and uptake of a luminal domain antibody against synaptotagmin indicating functional
actively recycling terminals. Induced presynaptic sites are differentiated from endogenous axon-dendrite synapses by lack of apposingMAP2-positive dendrites.
(B) Myc-calsyntenin-3-CFP (Myc-C3-CFP) expressed in COS cells induces clustering of synapsin at contact sites with tau-positive axons lacking associated
MAP2-positive dendrites. CFP-neuroligin-2 (CFP-Nlg2) has similar synaptogenic activity, whereas cocultures with mCFP show only endogenous axon-dendrite
synapses.
(C and D) Quantitation of the total integrated intensity of synapsin immunofluorescence associated with COS cells expressing the indicated CFP fusion protein
and not associated withMAP2 divided by the COS cell area (C) or divided by the tau-positive axon-COS cell contact area (D). ANOVA, p < 0.0001 (n = 30 cells from
three independent experiments); *p < 0.001 compared to mCFP by post hoc Bonferroni multiple comparison test; p > 0.05 Myc-calsyntenin-3-CFP compared
with CFP-neuroligin-2.
(E) Myc-calsyntenin-3-CFP (Myc-C3-CFP) expressed in COS cells induces glutamatergic excitatory marker VGlut1 clustering in contacting axons. Absence of
associated PSD-95 family proteins was used to exclude interneuronal synapses. N-cadherin-CFP (N-cad-CFP) lacks similar synaptogenic activity.
(F) Myc-calsyntenin-3-CFP (Myc-C3-CFP) expressed in COS cells induces GABAergic inhibitory marker VGAT clustering in contacting axons. Absence of
associated gephyrin was used to exclude interneuronal synapses. N-cadherin-CFP (N-cad-CFP) lacks similar synaptogenic activity.
(legend continued on next page)
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a-Neurexin Partner Calsyntenin-3 Promotes Synapsesand LRRTM2 bind a- and b-neurexins lacking an insert at splice
site 4, whereas cerebellin1 bridges postsynaptic GluRd2 to
neurexins containing an insert at splice site 4 (de Wit et al.,
2009; Ko et al., 2009; Linhoff et al., 2009; Siddiqui et al.,
2010; Uemura et al., 2010). Neurexins and these diverse post-
synaptic binding partners control multiple aspects of synapse
development, including stabilization and morphological and
functional maturation (Ito-Ishida et al., 2012; Kwon et al.,
2012; Soler-Llavina et al., 2011; Uemura et al., 2010; Varo-
queaux et al., 2006). Modulators of synapse-organizing com-
plexes also regulate synapse development. For example,
MDGA1 reduces inhibitory synapse density by blocking the
interaction of neuroligin 2 with neurexins (Pettem et al., 2013).
In the present study, we employed an unbiased screen for syn-
aptogenic proteins to identify calsyntenin-3 as a synapse-orga-
nizing protein. Calsyntenin-3, also known as alcadein-b
(Alzheimer-related cadherin-like protein b), is a brain-specific
transmembrane protein with extracellular cadherin and LNS
domains and subject to ectodomain shedding (Araki et al.,
2003, 2004; Hintsch et al., 2002). We present evidence here
indicating that calsyntenin-3 is an a-neurexin-specific binding
partner essential for proper excitatory and inhibitory synapse
development.
RESULTS
An Unbiased Expression Screen Identifies Calsyntenin-
3 as a Synaptogenic Protein
We performed an unbiased mammalian expression screen that
we developed to identify novel proteins involved in synapse
development (Linhoff et al., 2009). The assay is based on cocul-
tures of nonneuronal cells with neurons following a strategy first
used to demonstrate the synaptogenic activity of neuroligins
(Scheiffele et al., 2000). Pools of a custom cDNA expression
library from developing rat brain were expressed in COS cells
that were then cocultured with rat hippocampal neurons and
assessed for their ability to induce presynapse differentiation in
contacting axons (Figures S1A and S1B available online). A pos-
itive cDNA library pool, PC151, was identified that induced hemi-
synapse formation between a COS cell and neurons, as shown
by the clustering of synapsin in the absence of excitatory or
inhibitory postsynaptic scaffold PSD-95 family proteins or ge-
phyrin (to exclude endogenous axon-dendrite synapses). This
positive pool was further screened by PCR and found to lack
cDNAs encoding known synaptogenic factors, including neuro-
ligins and LRRTMs (data not shown). Hence, we subdivided
PC151 into successively smaller pools that we tested for synap-
togenic activity and ultimately identified the single active clone to
encode calsyntenin-3. Calsyntenin-3 (Hintsch et al., 2002), also
known as alcadein-b (Araki et al., 2003), is a single-pass trans-
membrane protein that is highly enriched in brain but functionally
poorly understood.(G and H) Quantitation of the percentage of COS cells expressing the indicated CF
gephyrin (H). ANOVA, p < 0.0001 (nR 3 experiments countingR100 cells per exp
Bonferroni multiple comparison test.
Scale bars, 20 mm. Data are presented as mean ± SEM. See also Figure S1.Calsyntenin-3 Induces Excitatory and Inhibitory
Presynapse Differentiation
To better assess synaptogenic function of calsyntenin-3, we
added a Myc tag at its mature N terminus and a CFP tag at its
C terminus. These tags did not alter the activity of calsyntenin-
3 to induce clustering of synapsin in the coculture assay (Figures
S1C and S1D). Myc-calsyntenin-3-CFP also induced clustering
of the synaptic vesicle protein synaptophysin and the active
zone protein bassoon (Figure S1E). Moreover, Myc-calsyntenin-
3-CFP induced uptake of an antibody against the luminal domain
of synaptotagmin that becomes accessible on the neuronal sur-
face only during active recycling of vesicles (Figure 1A). Thus,
calsyntenin-3 induces the differentiation of functional presynap-
tic terminals. Similar to CFP-neuroligin-2 (Figure 1C), Myc-
calsyntenin-3-CFP induced a 24.6-fold increase in synapsin
clustering in isolated axons contacting transfected COS cells,
as compared to control protein membrane-associated CFP
(mCFP). Myc-calsyntenin-3-CFP induced a 2.4-fold increase
relative to mCFP in tau-positive axon contact area with trans-
fected COS cells (Figure S1F), indicating that calsyntenin-3 pro-
motes adhesion to axons. However, even after normalizing per
axon-COS cell contact area, Myc-calsyntenin-3-CFP induced
a 10.1-fold increase in synapsin clustering as compared to
mCFP (Figure 1D), indicating that calsyntenin-3 directly and
potently induces presynapse differentiation in contacting axons
independently of promoting adhesion.
We next tested whether calsyntenin-3 specifically induces
glutamatergic or GABAergic presynapse differentiation. Myc-
calsyntenin-3-CFP in COS cells induced clustering of vesicular
glutamate transporter VGlut1 and of vesicular GABA transporter
VGAT in contacting axons in hippocampal neuron coculture at
sites lacking apposed PSD-95 or gephyrin, respectively (Figures
1E–1H). Thus, calsyntenin-3 induces differentiation of glutama-
tergic and GABAergic presynaptic specializations.
The calsyntenin family contains two other members that share
51%–53% amino acid sequence identity with calsyntenin-3
(Hintsch et al., 2002). We thus tested calsyntenin-1 and calsyn-
tenin-2 for synaptogenic activity in the coculture assay, both in
untagged form andwithMyc andCFP tags to confirm expression
as for calsyntenin-3. However, calsyntenin-1 and calsyntenin-2
were unable to induce synapsin clustering in contacting hippo-
campal axons (Figure S1G) or cortical axons (data not shown).
Calsyntenin-3 Is a Selective a-Neurexin Binding Partner
Calsyntenin-3 induces presynapse differentiation in coculture
assays presumably by binding to a protein on axons. Two main
families of axonal proteins have been found to mediate presy-
napse differentiation, neurexins and type II protein tyrosine
phosphatases (PTPs), which each bind multiple postsynaptic
partners (Siddiqui and Craig, 2011; Takahashi and Craig,
2013). Thus, we tested for interactions of calsyntenin-3 with rep-
resentatives of the neurexin and PTP families. Purified solubleP fusion that induced clusters of VGlut1 lacking PSD-95 (G) or of VGAT lacking
eriment); *p < 0.001 compared to negative control N-cadherin-CFP by post hoc
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Figure 2. Calsyntenin-3 Binds and Is Recruited by a-Neurexins but Not b-Neurexins
(A) Like neuroligin-2-Fc (Nlg2-Fc), calsyntenin-3 fusion protein Clstn3-Fc bound to COS cells expressingHA-neurexin-1a (HA-Nrx1a) but did not bind toCOS cells
expressing HA-PTPs or HA-PTPd. The neurexin-1a variant lacking the insert at splice site 4 was used for (A)–(C).
(B) By Scatchard analysis, affinity of binding of Clstn3-Fc to HA-Nrx1a expressed on COS cells was estimated at 43.7 nM (nR 15 cells each).
(C) Binding of Clstn3-Fc to neurexin Nrx1a-CFP was abolished in calcium-free media containing 50 mM EGTA. *p < 0.0001, Student’s t test (n = 24 cells each).
(D) Clstn3-Fc bound to COS cells expressing all a-neurexin isoforms tested, a-neurexins 1, 2, and 3 containing (+S4) or lacking (S4) the insert at splice site 4.
Clstn3-Fc did not bind to COS cells expressing any b-neurexin isoform tested; 2b0 and 3b0 contain the LNS domain from neurexin 2 or 3, respectively, fused to
neurexin-1b-flanking sequences.
(E) Quantitation of Clstn3-Fc bound to COS cells expressing neurexin-1a or neurexin-1b containing (+S4) or lacking (S4) the insert at splice site 4 or to
nontransfected control cells. ANOVA p < 0.0001 (nR 20 cells each); *p < 0.001 compared to control by post hoc Bonferroni multiple comparison test.
(F) In a recruitment assay, neurons expressing Myc-calsyntenin-3DPCS (Myc-C3DPCS) were cocultured with COS cells expressing the indicated neurexin
isoforms tagged with CFP. The a-neurexins but not b-neurexins in COS cells recruited Myc-C3DPCS to contact sites.
(G) Quantitation of the percentage of COS cells expressing the indicated neurexin that induced clustering of Myc-C3DPCS in contacting neuronal processes.
ANOVA, p < 0.0001 (n = 3 experiments).
(legend continued on next page)
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a-Neurexin Partner Calsyntenin-3 Promotes Synapsesfusion protein of the calsyntenin-3 ectodomain with human
immunoglobulin constant region, calsyntenin-3-Fc, bound to
COS cells expressing neurexin-1a, but not to cells expressing
PTPs or PTPd (Figure 2A). Saturable binding was observed,
and Scatchard analysis revealed an apparent dissociation con-
stant of 43.7 nM for the interaction of calsyntenin-3-Fc with
cell-expressed neurexin-1a (Figure 2B), suggesting a physiolog-
ically significant interaction. Interaction of neurexins with many
partners is calcium dependent. Indeed, binding of calsyntenin-
3-Fc to neurexin-1a was abolished in nominally calcium-
free buffer containing 50 mM EGTA (Figure 2C) indicating a
calcium-dependent interaction.
As discussed above, neurexin promoter usage and alternative
splicing at site 4 control its extracellular interactions. Thus, we
testedmultiple neurexin variants for their interaction with calsyn-
tenin-3. When expressed in COS cells, all tested a-neurexins (1,
2, and 3 with or without an insert at splice site 4) bound calsyn-
tenin-3-Fc, whereas none of the six b-neurexin variants tested
bound calsyntenin-3-Fc (Figure 2D). Quantification of neurexin-
1 binding showed that only neurexin-1a, but not neurexin-1b,
mediated significant calsyntenin-3 binding as compared with
nontransfected cells, and the presence or absence of an insert
at splice site 4 in neurexin-1a did not affect the apparent affinity
for calsyntenin-3-Fc (Figure 2E). We further tested the specificity
of interactions in a cell-based recruitment assay. COS cells ex-
pressing all a but not b isoforms of neurexins 1, 2, and 3 tested
were able to recruit Myc-calsytenin-3DPCS expressed in neu-
rons to contact sites (Figures 2F, 2G, and S2; DPCS indicates
a small deletion to improve neuronal surface expression as
described further below). Thus, in this modified coculture assay,
the ectodomains of calsyntenin-3 on the neuron surface and
a-neurexins but not b-neurexins on the COS cell surface bound
in trans at cell-cell interaction sites.
To confirm the interaction of native calsyntenin-3 with a-neu-
rexin but not b-neurexin, we did pull-down experiments from
brain. Recombinant ectodomain proteins for neurexin-1a or
neurexin-1b were produced, attached to beads, and used
for affinity chromatography with cow brain synaptosomes.
Neurexin-1a ectodomain attached to beads, but not neurexin-
1b-GST or GST or beads alone, pulled down calsyntenin-3
from synaptosomes (Figure 2H). As a positive control for
neurexin-1b-GST, we found that this neurexin-1b ectodomain
efficiently pulled down neuroligins from synaptosomes as ex-
pected from previous studies (Boucard et al., 2005). Altogether,
these data identify a-neurexins as a selective binding partner
for calsyntenin-3.
Full-Length but Not Cleaved Calsyntenin-3 Induces
Presynapse Differentiation
In a manner similar to amyloid b-precursor protein, calsyntenin-3
is subject to primary membrane-proximal proteolytic cleavage(H) Pull-down of calsyntenin-3 from cow brain synaptosomes by neurexin-1a b
neurexin-1a ectodomain attached to beads in two independent experiments (lan
similar in size to calsyntenin-3 does not cross-react with the calsyntenin 3 antibo
neurexin-1b-GST (compare with GST or beads alone). Right blot, under the same
1b-GST but not GST or beads alone.
Scale bars, 10 mm. Data are presented as mean ± SEM. See also Figure S2.resulting in ectodomain shedding followed by secondary intra-
membranous cleavage by a presenilin-dependent g-secretase
(Araki et al., 2004; Hata et al., 2009). To determine whether
the full-length and/or cleaved ectodomain forms are present in
brain, we generated an antibody that detects an extracellular
epitope present in calsyntenin-3, but not the related calsynte-
nin-1 or calsyntenin-2 (Figure 3A; validated against tissue
lacking calsyntenin-3 in Figure 7B). In mouse brain homogenate,
this antibody detected the full-length and large cleaved extra-
cellular fragment of calsyntenin-3 in roughly equal amounts
(Figure 3A). Thus, about half of the calsyntenin-3 in brain is pre-
sent in the cleaved form. The degree of calsyntenin-3 cleavage
may even be higher because some of the cleavage products
may end up in the cerebrospinal fluid (Hata et al., 2011; Vogt
et al., 2001).
To determine which calsyntenin-3 variants have synaptogenic
activity, we generated a series of deletion constructs from Myc-
calsyntenin-3-CFP and tested them for cleavage and synapto-
genic activity in the coculture assay (Figures 3B–3E). Deleting
the intracellular domain did not reduce synaptogenic activity
(comparing Myc-C3EXTM-CFP to Myc-calsyntenin-3-CFP),
and the intracellular domain alone (C3intracell-CFP) was not
active. Deleting 20 amino acids surrounding the primary cleav-
age site (Myc-C3DPCS-CFP) or replacing the region from the pri-
mary cleavage site to the end of the transmembrane domain with
the transmembrane domain of the unrelated lymphocyte protein
CD8 (Myc-C3EX-CD8-C3IN) did not reduce synaptogenic activ-
ity, nor did these manipulations block partial cleavage in COS
cells. We thus fused only the extracellular region of calsynte-
nin-3 up to the primary cleavage site to a partial CD8-CFP fusion
and found that this construct, Myc-C3EX-CD8-CFP, showed no
cleavage in COS cells, yet exhibited a similar synaptogenic activ-
ity as Myc-calsyntenin-3-CFP. Thus, calsyntenin-3 cleavage is
not essential for synaptogenic activity. Furthermore, when
Myc-tagged calsyntenin-3 ectodomain (Myc-C3secreted) was
expressed and released into the media, mimicking the cleaved
ectodomain, no synaptogenic activity was observed. Thus, the
transmembrane form of calsyntenin-3 is synaptogenic, and pro-
teolytic release of its ectodomain abolishes the synaptogenic
activity of calsyntenin-3.
Released Calsyntenin-3 Ectodomain Inhibits the
Synaptogenic Activity of Multiple a-Neurexin Partners
We wondered further whether the released calsyntenin-3 ecto-
domain might have antisynaptogenic activity by competing
with full-length calsyntenin-3. The free calsyntenin-3 ectodo-
main might bind to a-neurexin along axons without triggering
its local aggregation, thus blocking binding of full-length
calsyntenin-3 and potentially other synaptogenic partners to
a-neurexin and counteracting their presynaptic-inducing
activity. To test this idea, we coexpressed Myc-C3secretedut not neurexin-1b. Left blot shows that calsyntenin-3 was pulled down by
es 3 and 4), but not beads alone (lane 6). Neurexin-1a ectodomain bait that is
dy (lane 5). Middle blot shows that calsyntenin-3 could not be pulled down by
conditions, demonstrates that neuroligins (Nlgs) were pulled down by neurexin-
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Figure 3. Full-Length Calsyntenin-3 Is Synaptogenic, but Cleaved Calsyntenin-3 Inhibits the Synaptogenic Activity of a-Neurexin Partners
(A) An antibody raised against an N-terminal region of calsyntenin-3 recognizesMyc-calsyntenin-3 (Myc-C3) and shows little or no signal for Myc-calsyntenin-1 or
Myc-calsyntenin-2 (Myc-C1, Myc-C2) expressed in COS cells. In mouse brain homogenate, the two major bands correspond to full-length calsyntenin-3 and the
cleaved extracellular fragment. The COS cell lysate analyzed here contains mainly full-length calsyntenin-3; the cleaved extracellular fragment is found mainly in
COS cell media.
(B) Domain structure of Myc-calsyntenin-3-CFP and variants: CAD, cadherin domain; LNS, laminin neurexin sex hormone binding protein domain; TM, trans-
membrane domain; Intra, intracellular domain; CD8TM, the calsyntenin-3 transmembrane domain was replaced with the CD8 lymphocyte protein trans-
membrane domain.
(C) Western blot with anti-Myc antibody of lysate and media from COS cells expressing the indicated constructs confirms secretion of Myc-C3secreted and
indicates that Myc-C3EX-CD8-CFP was not cleaved, whereas all other constructs assayed were partially cleaved generating large fragments in the media.
(D) Representative images of calsyntenin-3 variants in the coculture assay. All membrane-associated forms with the calsyntenin-3 extracellular domain are
synaptogenic, including the noncleavable Myc-C3EX-CD8-CFP.
(E) Quantitation of the percentage of COS cells expressing the indicated construct that induced clusters of synapsin lackingMAP2 in the coculture assay. ANOVA,
p < 0.0001 (nR 3 experiments countingR100 cells per experiment),Ap < 0.001 compared to negative control N-cadherin-CFP by post hoc Bonferroni multiple
comparison test; *p < 0.001 compared to Myc-C3-CFP by post hoc Bonferroni multiple comparison test.
(F) Representative coculture images showing suppression of synaptogenic activity of CFP-tagged a-neurexin partners neuroligin 2 (Nlg2), calsyntenin-3 (Clstn3),
and LRRTM2 by coexpression ofMyc-C3secretedmimicking the shed calsyntenin-3 ectodomain as comparedwith coexpression of AP control. Myc-C3secreted
had no effect on Slitrk2, which acts via a nonneurexin presynaptic partner. Cocultures were immunolabeled for synapsin (red) and MAP2 (green).
(legend continued on next page)
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Figure 4. The Cadherin and LNS Domains Are Required for Calsyntenin-3 Synaptogenic Activity and a-Neurexin Binding
(A) Domain structure of calsyntenin variants. The darker and lighter shading for calsyntenin-1 (C1) and calsyntenin-2 (C2) represents different but similar amino
acid sequences as compared with calsyntenin-3 (C3).
(B) Quantification of the percentage of COS cells expressing the indicated construct that induced clusters of synapsin lacking MAP2 in the coculture assay (left)
and binding of neurexin-1a-AP to the indicated constructs expressed in COS cells (right). ANOVA, p < 0.0001 (n = > 30 cells each). *p < 0.01 compared to negative
control N-cadherin-CFP by post hoc Bonferroni multiple comparison test.
Data are presented as mean ± SEM.
See also Figure S3.
Neuron
a-Neurexin Partner Calsyntenin-3 Promotes Synapsesmimicking the shed calsyntenin-3 ectodomain, or the presum-
ably inert secreted protein alkaline phosphatase (AP) as a
control, along with calsyntenin-3DPCS or other synaptogenic
proteins neuroligin-2, LRRTM2, or Slitrk2. Indeed, Myc-
C3secreted compared with control AP significantly reduced pre-
synaptic induction by calsyntenin-3DPCS, or by neuroligin-2 or
LRRTM2, which act through binding neurexins (a-neurexins
in part) (Boucard et al., 2005; Siddiqui et al., 2010), but not
by Slitrk2, which acts through binding PTPs (Yim et al., 2013)
(Figures 3F and 3G). Thus, the released calsyntenin-3 ecto-
domain inhibits the presynaptic-inducing activity of full-length
calsyntenin-3 and of other a-neurexin partners neuroligin and
LRRTM.
Cadherin and LNS Domains of Calsyntenin-3 Are
Necessary for a-Neurexin Binding and for Synaptogenic
Activity
We generated another series of deletion constructs to map the
domains of calsyntenin-3 important for neurexin binding and
for presynaptic-inducing activity (Figure 4A). Calsyntenin-3 ex-
pressed on COS cells mediated binding of neurexin-1a ectodo-
main fused to AP (neurexin-1a-AP), but not of neurexin-1b-AP,(G) Quantification of suppression of synaptogenic activity of a-neurexin partners
cells and lacking MAP2 were measured. ANOVA, p < 0.0001 (n = > 30 cells eac
multiple comparison test.
Scale bars, 20 mm. Data are presented as mean ± SEM.further confirming the interaction (Figure S3A). We then assayed
Myc-calsyntenin-3-CFP and mutants for binding of neurexin-
1a-AP and for synaptogenic activity in the coculture assay (Fig-
ure 4B). Deleting the cadherin domains (Myc-C3DCAD-CFP)
abolished both neurexin binding and synaptogenic activity, indi-
cating that the cadherin domains are essential. However, the
cadherin domains alone (Myc-C3CADonly-CFP) expressed on
the COS cell surface were unable to bind neurexin-1a-AP or
induce presynapse differentiation in coculture. Furthermore, de-
leting the LNS domain abolished both neurexin binding and
synaptogenic activity. All mutants tested reached the COS cell
surface with efficiencies similar to or better than Myc-calsynte-
nin-3-CFP (Figure S3B); thus, deficits in binding or synaptogenic
activity were not due to trafficking alterations. We also tested a
point mutation in the LNS domain Q441/K mimicking a muta-
tion E/K in the C. elegans single calsyntenin ortholog
CASY-1, which results in defects in learning (Ikeda et al.,
2008). This LNS point mutation significantly reduced but did
not abolish both a-neurexin binding and synaptogenic activity.
These data indicate that the cadherin and LNS domains of
calsyntenin-3 are essential for a-neurexin binding and for synap-
togenic activity.by Myc-C3secreted. Clusters of synapsin associated with CFP-positive COS
h); ***p < 0.001 and *p < 0.05 compared to AP control by post hoc Bonferroni
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a-Neurexin Partner Calsyntenin-3 Promotes SynapsesWe next tested tagged calsyntenin-1 and calsyntenin-2 for
a-neurexin binding and, consistent with the lack of coculture
activity, found that these calsyntenin family members could not
mediate binding of neurexin-1a-AP (Figure 4). However, these
constructs, Myc-calsyntenin-1-CFP and Myc-calsyntenin-2-
CFP, showed poor surface trafficking as compared with Myc-
calsyntenin-3-CFP (Figure S3). Thus, we generated variants
with better surface expression. Myc-C1EX-CD8-CFP and Myc-
C2EX-CD8-CFP containing the extracellular domains up to the
primary cleavage sites trafficked well to the COS cell surface,
yet could not mediate binding of neurexin-1a-AP or presynaptic
induction in coculture, unlike the homologous Myc-C3EX-CD8-
CFP (Figures 4 and S3). Thus, among the calsyntenins, calsynte-
nin-3 may be unique in its ability to bind a-neurexin and
induce presynapse differentiation. Altogether, the correlation
for multiple constructs between a-neurexin binding and cocul-
ture activity (Figure 4) supports the idea that a-neurexinmediates
the presynaptic-inducing activity of calsyntenin-3.
Overexpression of Calsyntenin-3DPCS in Neurons
Promotes Glutamatergic and GABAergic Presynapse
Differentiation
Next, we assessed the effect of elevating calsyntenin-3 levels on
synaptic differentiation in cultured neurons. However, unlike in
brain where the ratio of full-length to cleaved calsyntenin-3 is
about equal (Figure 3A), endogenous calsyntenin-3 was primarily
detected in cleaved form in cultured neurons (>90% cleaved;
Figure S4C). Furthermore, recombinant Myc-calsyntenin-3 did
not accumulate on the surface of cultured hippocampal neurons,
although it accumulated on the surface of COS cells. Myc-
calsyntenin-3DPCSwith a small deletion at the primary cleavage
site showed significantly reduced cleavage allowing accumula-
tion on the neuron surface (Figures S4A and S4B) and was
therefore used to assess effects of overexpression. Similar to
CFP-neuroligin-2, overexpression of Myc-calsyntenin-3DPCS
significantly enhanced clustering of VGlut1, VGAT, and synapsin
at inputs onto transfected dendrites as compared to neurons
expressing only CFP or neighboring nontransfected neurons
(Figures 5 and S4). Thus, dendritic surface expression of
calsyntenin-3DPCS promotes excitatory and inhibitory presy-
napse differentiation in contacting axons. We then attempted
to determine whether the noncleavable Myc-C3EX-CD8-CFP
also enhanced presynapse differentiation in cultured neurons,
but unlike the partially cleavableMyc-C3EX-CD8-C3IN, this non-
cleavable construct did not accumulate on the dendrite surface
(Figures S4D–S4F).
The markedly different ratios of full-length to cleaved
calsyntenin-3 in neuron culture as compared with in vivo (Fig-
ure S4C) and the opposing biological effects of these forms of
the protein (Figure 3) prompted us to focus our attention next
on assessing calsyntenin-3 distribution and function in vivo.
Calsyntenin-3 Shows Differential Expression Patterns
In Vivo
The developmental expression and cleavage profiles of
calsyntenin-3 were determined between postnatal days (P) 6
and P60 by western blot analysis with the N-terminal antibody.
Only modest nonsignificant changes in levels of calsyntenin-3120 Neuron 80, 113–128, October 2, 2013 ª2013 Elsevier Inc.or in the ratio of cleaved to full-length forms were observed
over this time frame (Figures 6A and 6B). The percentage of cal-
syntenin-3 in cleaved formwas always in the range of 52%–60%.
By immunofluorescence, calsyntenin-3 was detected widely
in brain including hippocampus and cortex (Figures 6C–6J) using
an antibody raised against a C-terminal peptide that was vali-
dated using tissue lacking calsyntenin-3 (see Figures 7A and
7B). The N-terminal antibody gave similar results (Figure S5).
Consistent with a previous report by Hintsch et al. (2002),
calsyntenin-3 was detected most strongly in interneurons identi-
fied here by their location outside the main cell body layers of
the hippocampus, by the absence of calcium-calmodulin-acti-
vated protein kinase IIa (CaMKIIa), and by the presence of
parvalbumin in a subset of interneurons. Calsyntenin-3 was
also detected at lower levels in CA1 and CA3 pyramidal neurons
in a pattern that was not detected in Clstn3/ tissue (Figures
6C–6J and 7A). In the dentate gyrus, scattered hilar neurons
and interneurons exhibited high levels of calsyntenin-3, whereas
granule cells showed little or no calsysntenin-3. In neocortex,
calsyntenin-3 was again most strongly expressed by interneu-
rons including parvalbumin-positive neurons but also expressed
by many pyramidal cells, particularly in layer V (Figures 6I, 6J,
and S6C). Calsyntenin-3 was detected in soma, proximal den-
drites, and additional processes. Although we did not detect
clear synaptic puncta of calsyntenin-3, this may be due to limita-
tions of antigen accessibility or antibody sensitivity because
electron microscopic analyses detected calsyntenin-3 most
prominently in postsynaptic specializations of asymmetric syn-
apses in hippocampus, cortex, and cerebellum (Hintsch et al.,
2002).
Clstn3–/– Mice Are Deficient in Inhibitory and Excitatory
Synapse Development
To determine the function of calsyntenin-3 in vivo, we generated
Clstn3/ mice (Figures S6A and S6B). Loss of calsyntenin-3
protein was confirmed by loss of calsyntenin-3 immunofluores-
cence in brain sections (Figure 7A) and by western blotting of
brain homogenates (Figure 7B). Levels of a-neurexin were
normal in Clstn3/ mouse brain crude synaptosome fractions
(Figure 7C). Clstn3/ mice showed no obvious deficits in sur-
vival or fertility. The overall brain morphology of Clstn3/ mice
was normal, aswas the overall organization of the excitatory syn-
apse marker VGlut1 and the inhibitory synapse marker glutamic
acid decarboxylase GAD65 (Figures 7A, 7E, and S6). However,
quantitative high-resolution confocal analysis of hippocampal
CA1 and dentate gyrus regions revealed significant regional re-
ductions in VGlut1 and global reductions in GAD65 punctate
immunofluorescence in mice lacking calsyntenin-3 as compared
to wild-type littermate controls (Figure 7D).
To determine whether the reductions in punctate VGlut1 and
GAD65 immunofluorescence in CA1 ofClstn3/mice represent
reductions in excitatory and inhibitory synapse numbers, we
assessed asymmetric and symmetric synapse density by trans-
mission electron microscopy (Figure 7F). Indeed, asymmetric
synapse density was significantly reduced in CA1 stratum radia-
tum, and symmetric synapse density was significantly reduced
in CA1 stratum pyramidale in mice lacking calsyntenin-3
as compared to wild-type littermate controls (Figure 7G).
Figure 5. Calsyntenin-3DPCS Overexpression Enhances Excitatory and Inhibitory Presynaptic Inputs in Cultured Neurons
(A and D) Hippocampal neurons transfected at 8–9 DIV with Myc-calsyntenin-3 with a small deletion at the primary cleavage site (Myc-C3DPCS-CFP) or CFP-
neuroligin2 (CFP-Nlg2) but not CFP showed enhanced immunofluorescence for the excitatory input marker VGlut1 (A) and inhibitory input marker VGAT (D) as
compared to nontransfected neighbor neurons at 14 DIV. Arrows indicate transfected neurons; arrowheads indicate nontransfected neurons.
(B and E) At high magnification, the strong VGlut1 and VGAT signals onto dendrites expressing MycC3DPCS resolve into individual puncta.
(C and F) Quantitation of VGlut1 (C) and VGAT (F) immunopositive area per transfected dendrite length. ANOVA, p < 0.0001 (n = 20 cells each); *p < 0.001
compared to CFP by post hoc Bonferroni multiple comparison test.
Scale bars, 30 mm (A and D) and 10 mm (B and E). Data are presented as mean ± SEM. See also Figure S4.
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a-Neurexin Partner Calsyntenin-3 Promotes SynapsesNonsignificant reductions of >30% were also seen for asym-
metric synapses in stratum pyramidale and symmetric synapses
in stratum radiatum, regions of low synapse density. Thus, loss
of calsyntenin-3 results in reductions in both excitatory and
inhibitory synapse density.Clstn3–/– Mice Are Deficient in Inhibitory and Excitatory
Transmission
Wenext sought to determine if synaptic transmission is altered in
the absence of calsyntenin-3. We performed whole-cell record-
ings from CA1 pyramidal cells in Clstn3/ and wild-typeNeuron 80, 113–128, October 2, 2013 ª2013 Elsevier Inc. 121
Figure 6. Calsyntenin-3 Is Expressed by Neuron Subsets in Hippocampus and Cortex
(A and B) Western blot and quantification of the expression level and fraction of total calsyntenin-3 present as the cleaved form during development.
(C–J) Distribution of calsyntenin-3 (Clstn3, with C-terminal antibody) in adult mouse hippocampus (C–H) and cortex (I and J). Colabeling was performed for
parvalbumin (D, E, G, and I) and CaMKIIa (F, H, and J).
(C–H) In hippocampus, calsyntenin-3 immunoreactivity was detected most strongly in interneurons, both parvalbumin positive and parvalbumin negative
(arrowheads in E and G, respectively). Parvalbumin-negative interneurons were identified by their position outside the pyramidal cell layer and by the absence of
immunoreactivity for CaMKIIa (arrowheads in F and H). By comparison with Clstn3/ tissue (see Figure 7), wild-type pyramidal neurons (arrows) in CA1 (E and F)
and in CA3 (G and H) were also immunopositive for calsyntenin-3, whereas no immunoreactivity was detectable in dentate granule cells.
(I and J) In neocortex, calsyntenin-3 was widely expressed, at highest levels by interneurons (arrowheads) including parvalbumin-positive interneurons (I) but also
by some pyramidal neurons particularly in layer V (arrows in J).
Scale bars, 200 mm (C and D) and 50 mm (E–J). Data are presented as mean ± SEM. See also Figure S5.
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a-Neurexin Partner Calsyntenin-3 Promotes Synapseslittermate hippocampal slices to quantify spontaneous miniature
inhibitory postsynaptic currents (mIPSCs) and miniature excit-
atory postsynaptic currents (mEPSCs). Relative to wild-type
littermates, mIPSC recordings from Clstn3/ slices revealed a
reduction in mIPSC frequency but not amplitude (corresponding
to an increased interevent interval, Figures 8A–8C). Similarly,
comparisons of mEPSCs from Clstn3/ and wild-type mice
revealed reductions in frequency, but not amplitude (Figures
8D–8F). Taken together, these data indicate that calsyntenin-3
is required for normal development of functional inhibitory and
excitatory synapses.
To determine if the loss of calsyntenin-3 affects neurotrans-
mitter release probability, we measured paired-pulse facilitation
with field EPSP (fEPSP) recordings in CA1 stratum radiatum in
response to stimulation of Schaffer collateral fibers. No signifi-122 Neuron 80, 113–128, October 2, 2013 ª2013 Elsevier Inc.cant differences between mutant and control slices were de-
tected (Figure 8G). These data suggest that calsyntenin-3 does
not alter transmitter release probability and, along with the
mPSC recordings (Figures 8A–8F) and confocal and ultrastruc-
tural imaging data (Figures 7D–7F), are consistent with the idea
that loss of calsyntenin-3 reduces excitatory and inhibitory
synapse density. We next monitored input/output curves in
response to stepwise increases in stimulation intensity to deter-
mine if basal-evoked synaptic responses are altered inClstn3/
mice. At the higher end of the stimulation range, fEPSP re-
sponses from Clstn3/ hippocampal slices were significantly
enhanced relative to wild-type littermate controls (Figure 8H).
These data suggest that the net deficit in inhibitory transmission
in Clstn3/ hippocampus may slightly outweigh the deficit in
excitatory transmission to alter overall circuit excitability.
Neuron
a-Neurexin Partner Calsyntenin-3 Promotes SynapsesDISCUSSION
From an unbiased expression screen, we identified calsyntenin-
3 as a synaptogenic protein. Calsyntenin-3, but not the related
calsyntenin-1 or calsyntenin-2, can trigger excitatory and inhibi-
tory presynapse differentiation in contacting axons. We show
with cell-based binding and recruitment assays and pull-down
from brain that calsyntenin-3 specifically binds a-neurexins
and not b-neurexins. Calsyntenin-3 undergoes prominent ecto-
domain shedding with at least half of calsyntenin-3 in mouse
brain present in the cleaved form. Full-length calsytenin-3 is syn-
aptogenic in coculture, and a small deletion at the primary
cleavage site allows calsyntenin-3 to accumulate on the den-
dritic surface of cultured neurons and to enhance presynapse
differentiation. However, the released ectodomain of calsynte-
nin-3 not only lacks synaptogenic activity but also inhibits the
presynaptic-inducing activity of multiple a-neurexin partners.
Calsyntenin-3 is highly expressed by interneurons throughout
hippocampus and cortex and is expressed at lower levels by
many pyramidal neurons. Clstn3/ mice show reduced punc-
tate immunofluorescence for GAD65 and VGlut1, reduced den-
sity of symmetric and asymmetric synapses, and reduced
mIPSC and mEPSC frequency in hippocampal CA1 neurons.
Together, these data suggest that an a-neurexin-calsyntenin-3
complex is essential for normal inhibitory and excitatory synapse
development and function.
Unlike the binding specificity of calsyntenin-3 for a-neurexins,
other neurexin partners, neuroligins, LRRTMs, cerebellin-GluRd,
dystroglycan, and latrophilin, bind a- and b-neurexins or just
b-neurexins (Boucard et al., 2005, 2012; Matsuda and Yuzaki,
2011; Siddiqui et al., 2010; Sugita et al., 2001; Uemura et al.,
2010). Neurexin splice site 4, a key molecular switch that affects
interactions with many of these partners, did not appear to affect
the interaction with calsyntenin-3 (Figures 2 and S2). Mice lack-
ing all three a-neurexins but with normal expression of b-neurex-
ins die at birth due to impaired synaptic transmission linked to
deficits in presynaptic calcium channel currents (Missler et al.,
2003). Clstn3/ mice exhibit relatively normal survival and lack
the profound reductions in evoked synaptic transmission that
were detected in mice lacking a-neurexins (Figures 7 and 8).
Thus, it seems likely that neurexin partners other than calsynte-
nin-3 mediate its presynaptic calcium channel recruitment
function. However, we found a similar reduction in density of
inhibitory synapses in mice lacking calsyntenin-3 as found in
mice lacking a-neurexins. The small but significant increase in
input-output curve in Clstn3/ CA1 region compared with
wild-type controls supports the idea that the contribution of
calsyntenin-3 to inhibitory synapse development is important
for circuit function. However, the near normality of the input-
output curve may be misleading given the parallel reductions
in mEPSC and mIPSC frequency that indicate significant
deficits in excitatory and inhibitory transmission in the absence
of calsyntenin-3.
In the simplest model, full-length calsyntenin-3 may act as a
postsynaptic cell adhesion and synapse-organizing protein,
similar to neuroligins and LRRTMs and other presynaptic-
inducing proteins identified from this screen. This model is
consistent with the ability of calsyntenin-3 to induce presynap-tic specializations when presented to axons in trans on COS
cells or upon dendritic overexpression of calsyntenin-3DPCS
(Figures 1 and 5). Although we were unable to detect specific
synaptic localization, electron microscopy showed prominent
enrichment of calsyntenin-3 in the postsynaptic specializations
of asymmetric synapses in hippocampus, cortex, and cere-
bellum (Hintsch et al., 2002). The deficits observed in excitatory
synapses could be explained by this simple model: VGlut1
puncta, asymmetric synapse density, and mEPSC frequency
were reduced in Clstn3/ CA1 neurons, which normally ex-
press calsyntenin-3, whereas VGlut1 immunofluorescence
was unchanged at inputs onto dentate granule cells, which ex-
press little or no calsyntenin-3. Even in this simplest model,
extensive calsyntenin-3 cleavage differentiates it from other
synaptogenic proteins, and our data suggest that the cleaved
form may be important in buffering the synaptogenic activity
of a-neurexin partners, perhaps balancing overall synapse
development.
However, considering the multiple unique characteristics of
calsyntenin-3, its prominent intracellular pools detected with
our N- and C-terminal antibodies (Figures 6 and S5), and its
functional importance for both inhibitory and excitatory synapse
development (Figures 7 and 8) as well as its high degree of
cleavage (Figure 6), calsyntenin-3 may act instead or in addition
by a distinct mechanism from other known neurexin ligands.
We detected Myc-calsyntenin-3DPCS on the surface of
transfected axons as well as dendrites. Although the level of
a-neurexin in crude synaptosomes was not affected by loss
of calsyntenin-3 (Figure 7C), the possibility remains that calsyn-
tenin-3 might interact in cis with a-neurexin to regulate neurexin
trafficking or function. Indeed, loss of calsyntenin-3 resulted in
widespread deficits in inhibitory synapses, evidenced by loss of
GAD65 even onto dentate granule cells that normally express
little or no calsyntenin-3, possibly resulting from loss of calsyn-
tenin-3 in interneurons. Further work is needed to assess
subcellular distribution and circuit contributions of full-length
and cleaved calsyntenin-3 in interneurons as compared with
pyramidal cells and to determine the mechanisms by which
calsyntenin-3 regulates synapse development, whether as
inducer or modulator.
Calsyntenin-3 undergoes proteolytic processing in a manner
similar to amyloid precursor protein, involving primary cleavage
that releases a large extracellular fragment, followed by second-
ary intramembranous cleavage by g-secretase (Hata et al.,
2009). Neuroligin-1 was also recently found to undergo regulated
ectodomain cleavage (Peixoto et al., 2012; Suzuki et al., 2012).
However, whereas the vast majority of neuroligin-1 in brain is
present as the full-length form (Peixoto et al., 2012), less than
half of the calsyntenin-3 in brain is present as full-length form
and over half as the shed ectodomain (Figure 6). Recombinant
calsyntenin-3 can be partially cleaved by ADAM-10 and
ADAM-17 (Hata et al., 2009), although the identity of the primary
proteases in brain has not been determined. In cultured neurons,
nearly all calsyntenin-3 was cleaved, and we were unable to
inhibit cleavage despite assaying a large range of protease inhib-
itors (data not shown). Perhaps like the related calsyntenin-1
(Maruta et al., 2012), calsyntenin-3 may be largely cleaved
en route to the cell surface. We suspect that calsyntenin-3Neuron 80, 113–128, October 2, 2013 ª2013 Elsevier Inc. 123
Figure 7. Clstn3–/– Mice Show Reduced Inhibitory and Excitatory Synaptic Development
(A) Immunofluorescence confirmation of loss of calsyntenin-3 immunoreactivity (using the C-terminal antibody) in hippocampus of Clstn3/ mice. Clstn3/
brains exhibited normal morphology and cellular distributions indicated with the DAPI nuclear costain.
(B) Western blot confirmation of loss of calsyntenin-3 (Clstn-3) protein detected with both C-terminal and N-terminal antibodies in Clstn3/ mouse brain ho-
mogenate with b-actin as loading control.
(C) Western blot and quantification showed that the level of a-neurexin was indistinguishable in crude synaptosome fractions ofClstn3/ andClstn3+/+ littermate
mice. Student’s t test, p > 0.05 (n = 3).
(D) Quantitation of VGlut1 and GAD65 punctate integrated intensity per tissue area from high-resolution images. ANOVA, p < 0.0001 (n = 5 mice each after
averaging data from six sections per mouse), age P30; *p < 0.01 and **p < 0.001 by post hoc Bonferroni multiple comparison test comparing Clstn3+/+ and
Clstn3/ for each region. VGlut1 and GAD65 were measured from the same regions of double-labeled sections.
(E) Clstn3+/+ and Clstn3/ mice showed no gross difference in hippocampal distribution of immunoreactivity for VGlut1, GAD65, or the nuclear marker DAPI,
imaged at low resolution.
(legend continued on next page)
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Figure 8. Inhibitory and Excitatory Neurotransmission Is Compromised in Clstn3–/– Mice
(A) Representative mIPSC recordings from hippocampal CA1 pyramidal neurons in acute slices from Clstn3+/+ and Clstn3/ adult mice.
(B and C) Cumulative distributions of mIPSC interevent intervals (B) and amplitudes (C) in Clstn3+/+ and Clstn3/ neurons (Kolmogorov-Smirnov test, p < 0.001
for interevent intervals). Insets display mean ± SEM for mIPSC frequency (B) and amplitude (C). mIPSC frequency but not amplitude was significantly reduced in
Clstn3/ neurons (Student’s t test, *p < 0.05; n = 11 cells, Clstn3+/+; n = 21 cells, Clstn3/).
(D) Representative mEPSC recordings from Clstn3+/+ and Clstn3/ hippocampal CA1 pyramidal neurons.
(E and F) Cumulative distributions of mEPSC interevent intervals (E) and amplitudes (F) in Clstn3+/+ and Clstn3/ neurons (Kolmogorov-Smirnov test, p < 0.001
for interevent intervals). Insets display mean ± SEM for mEPSC frequency (E) and amplitude (F). mEPSC frequency but not amplitude was significantly reduced in
Clstn3/ neurons (Student’s t test, *p < 0.01; n = 20 cells, Clstn3+/+; n = 22 cells, Clstn3/).
(G) Paired-pulse facilitation was assessed as the ratio of fEPSP slopes elicited by paired pulses in hippocampal CA1 stratum radiatum in response to stimulation
of Schaffer collateral fibers. No significant difference was observed between Clstn3+/+ (n = 12) and Clstn3/ (n = 8) mouse hippocampal slices.
(H) Basal-evoked synaptic responses were measured through comparison of input/output responses. At higher stimulation intensities, Clstn3/ fEPSP
responses were enhanced relative to Clstn3+/+ littermate controls (Student’s t test, *p < 0.05; n = 8 slices each).
Data are expressed as mean ± SEM for (G) and (H).
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a-Neurexin Partner Calsyntenin-3 Promotes Synapsescleavage and trafficking in neurons may be linked because the
partially cleavable Myc-C3DPCS-CFP and Myc-C3EX-CD8-
C3IN accumulated on the dendrite surface, but the noncleaved(F and G) Ultrastructure analysis showed asymmetric (arrows) and symmetric (arr
p < 0.0001 (n = 4 mice each after averaging data from more than 50 images pe
comparison test comparing Clstn3+/+ and Clstn3/ for each region.
Scale bars, 200 mm (A and E) and 500 nm (F). Data are expressed as mean ± SEMyc-C3EX-CD8-CFP did not (Figures 3 and S4). A better under-
standing of the regulation of calsyntenin-3 proteolytic process-
ing will be important considering our finding that full-lengthowheads) synapse loss in hippocampal CA1 region of Clstn3/mice. ANOVA,
r mouse per region), age P50–P60; *p < 0.01 by post hoc Bonferroni multiple
M. See also Figure S6.
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a-Neurexin Partner Calsyntenin-3 Promotes Synapsescalsyntenin-3 and the released ectodomain can have opposing
functions (Figure 3).
Calsyntenin-1 and calsyntenin-2 have a similar domain struc-
ture as calsyntenin-3, undergo similar cleavage (Araki et al.,
2004; Hata et al., 2009), and were also found to be enriched at
postsynaptic sites (Hintsch et al., 2002; Vogt et al., 2001). How-
ever, calsyntenin-1 and calsyntenin-2 lack synaptogenic activity,
and we could detect no interaction with neurexin (Figures 4 and
S1). Calsyntenin-1 was found to act as an organelle adaptor that
links kinesin-1 light chain to transport vesicles (Araki et al., 2007;
Konecna et al., 2006; Vagnoni et al., 2011). No role for calsynte-
nin-3 has been demonstrated in organelle transport. Indeed,
such a function may be unlikely because calsyntenin-3 lacks
one of the kinesin light-chain binding sites and has a variant res-
idue in the other that reduces the affinity of kinesin interaction
(Konecna et al., 2006). These differences in their proposed func-
tions, calsyntenin-3 in synapse development and calsyntenin-1
in vesicle transport, are also consistent with the higher COS7
cell surface expression we observed for tagged calsyntenin-3
as compared with calsyntenin-1 (Figure S3). Synapse-organizing
function is typically but not always shared among family mem-
bers; for example, TrkC but not TrkA or TrkB was found to
interact with PTPs to organize excitatory synapses (Takahashi
et al., 2011).
Based on their similar proteolytic processing as amyloid pre-
cursor protein (Araki et al., 2004), calsyntenins/alcadeins have
been suggested as biomarkers for Alzheimer’s disease. Indeed,
presenilin I mutations linked to familial Alzheimer’s disease alter
processing of all calsyntenins (Hata et al., 2009), and altered
levels of calsyntenin-1 and calsyntenin-3 products were found
in patients with Alzheimer’s disease (Hata et al., 2011; Vagnoni
et al., 2012) and in a mouse model (Uchida et al., 2011), respec-
tively. Multiple mechanisms have been suggested for a role of
calsyntenins in Alzheimer’s disease, including reduced transport
mediated by a calsyntenin kinesin-1 light-chain complex and
reduced stabilization of amyloid precursor protein by a triple
complex with X11L/Mint2 and calsyntenins (Araki et al., 2003).
The data presented here suggest an additional possibility: loss
of the synaptic-organizing function of calsyntenin-3 may
contribute to Alzheimer’s disease, particularly to the associated
cognitive decline.
The single calsyntenin ortholog in C. elegans, CASY-1, is
essential for multiple forms of associative learning, through
mechanisms that are not well understood but require the extra-
cellular domain of CASY-1 (Hoerndli et al., 2009; Ikeda et al.,
2008). Similar to our mapping showing the importance of calsyn-
tenin-3 cadherin and LNS domains for neurexin binding and syn-
aptogenic function (Figure 4), the cadherin and LNS domains of
CASY-1 were required to rescue chemotaxis learning (Ikeda
et al., 2008). Of the many variants in neurexins linked to cognitive
and psychiatric disorders, the majority affect a-neurexins and
not b-neurexins (Ching et al., 2010; Schaaf et al., 2012), and
calsyntenin-3 is the first a-neurexin-specific extracellular partner
of which we are aware other than the small neurexophilins. We
propose that calsyntenin-3 may contribute to cognitive perfor-
mance through its effects on synapse development and function
and suggest that further studies may be warranted on the role of
calsyntenin-3 in psychiatric disorders.126 Neuron 80, 113–128, October 2, 2013 ª2013 Elsevier Inc.EXPERIMENTAL PROCEDURES
Additional details are provided in the Supplemental Experimental Procedures.
Cell Culture and Transfection
Dissociated primary hippocampal neuron cultures were prepared from
embryonic day 18 rat embryos as described previously by Kaech and Banker
(2006). Neurons were plated at a density of 300,000 cells per 60 mm dish on
poly-L-lysine-coated coverslips and inverted over a feeder layer of glia. To
prevent overgrowth of glia, cytosine arabinoside (5 mM) was added to neuron
cultures at 2 days. Serum-free media were also supplemented with 100 mM
APV (Research Biochemicals) to prevent excitotoxicity during transfection or
coculture. For overexpression studies, neurons were transfected with 5–8 mg
of DNA per dish at 8–9 days in vitro (DIV) using the ProFection Mammalian
Transfection System (Promega) and fixed at 14 DIV.
COS7 and HEK293T cells were cultured in DMEM-H with 10% fetal bovine
serum. Transfections of COS7 cells were performed using TransIT-LT1 Trans-
fection Reagent (Mirus). Cocultures of primary hippocampal neurons with
COS7 cells were performed as described previously by Graf et al. (2004).
Briefly, transfected COS7 cells were trypsinized on the day after transfection
and resuspended in conditioned neuron culture media. Neurons grown for
9–10 DIV were inverted in their home dish, and COS cells were added. After
2 hr, the neuron coverslips were flipped back over so the neurons and COS
cells were facing the glial feeder layer. After 20–24 hr of coculture, cells were
fixed for analysis.
Expression Screen
An unamplified, full-length, size-selected cDNA expression library from rat
brain P11 was custom generated, and screening was performed as described
(Linhoff et al., 2009). Briefly, pools of plasmid DNA were generated from 200
colony-forming units grown in ultralow gelling agarose to promote uniform
amplification. Each pool of cDNA was transfected into COS cells that were
harvested by trypsinization after 7 or 24 hr and seeded onto neuron coverslips
pregrown for 8–9 DIV. Cocultures were fixed 20 hr later for screening. Pools
that generated COS cells with overlying axon-associated clustering of
synapsin lacking PSD-95 or gephyrin were tested by PCR for neuroligins,
netrin-G ligands, and LRRTMs. Positive-pool PC151 lacked these known
synaptogenic factors. PC151 glycerol stock was used to prepare and screen
subpools from 100 colony-forming units each. The subpool with strongest
activity was arrayed into 384-well plates of individual colonies, and plasmid
DNA was prepared and screened in rows and then by individual clone.
Immunofluorescence
The C-terminal antibody against calsyntenin-3 was raised in rabbits against
the peptide DSPSSDERRIIESPPHRY with an N-terminal cysteine for conjuga-
tion to the carrier protein keyhole limpet hemocyanin and affinity purified
against the peptide (RAP Affinity Purification Kit; Zymed). The N-terminal
antibody against calsyntenin-3 was raised in rabbits against a GST fusion
with the cadherin repeat region (KANKHKPW.QVKPTCKP) expressed from
the pGEX-4T-1 vector and purified from bacteria. All image analysis was
performed blind to experimental condition.
Binding Assays and Pull-Down
For cell-based binding assays, COS7 cells were transfected with the indicated
expression vectors and grown for 24 hr. Live cells were incubated with fusion
proteins (at 50 nM unless otherwise indicated) either for 1 hr at 20C or for
45 min at 4C. Fc fusions were visualized with FITC-conjugated anti-human
IgG and AP fusions with anti-AP antibody.
For the pull-down from brain, cow synaptosomes were prepared following a
previously described method by Villasana et al. (2006). Pull-down was per-
formed with hexahistidine-tagged neurexin-1a ectodomain coupled to Talon
beads or with neurexin-1b ectodomain fused to GST or GST control coupled
to glutathione beads. Elutions were performed with buffer containing 2%
SDS. Samples were analyzed by western blot with the C-terminal antibody
against calsyntenin-3 or with anti-neuroligin antibody (Synaptic Systems;
#129011).
Neuron
a-Neurexin Partner Calsyntenin-3 Promotes SynapsesElectron Microscopy
Clstn3/ and wild-type littermate mice were perfused transcardially with 4%
paraformaldehyde and then PBS. Brain tissue was collected and postfixed
with 4% paraformaldehyde for 24 hr. Hippocampal CA1 region was blocked
and fixed with osmium oxide, dehydrated, embedded in a JEMBED/Spurr’s
mixture, and 70 nm sections were generated and stained with 2% uranyl
acetate and Reynold’s lead. Images of stratum pyramidale (>100) and stratum
radiatum (>50) were obtained on a Hitachi H7600 transmission electronmicro-
scope. Symmetric and asymmetric synapses were visually identified and
counted.
Electrophysiology
Hippocampal slices were prepared from 6- to 10-week-oldClstn3/ andwild-
type littermates. Whole-cell recordings of CA1 neurons were performed with a
MultiClamp 700B amplifier using WinLTP software. mEPSCs were recorded
under voltage clamp at 60 mV with a Cs-methanesulfonate-based intracel-
lular solution in the presence of tetrodotoxin (TTX) and bicuculline. mIPSCs
were recorded at 70 mV with a CsCl-based intracellular solution in the pres-
ence of TTX, CNQX, and DL-AP5. Analyses for frequency and amplitude were
conducted using MiniAnalysis software. Statistical analyses were completed
using GraphPad InStat and SigmaPlot. Paired-pulse and input-output data
were obtained by extracellular recordings in CA1 stratum radiatum while stim-
ulating Schaffer collateral fibers. The initial slope of the fEPSP was measured
to quantify synaptic strength (Johnston and Wu, 1995).SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures can be found with this article online at http://dx.doi.org/10.
1016/j.neuron.2013.07.016.
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